Meningococcal disease in travelers: update on vaccine options.

Authors: Cramer JP,Wilder-Smith A,
Address: Section Infectious Diseases/Tropical Medicine, I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. cramer@bni-hamburg.de
Journal: Curr Opin Infect Dis.

Publication: 2012 Oct;25(5):507-17. doi: 10.1097/QCO.0b013e3283574c06.

abstract

PURPOSE OF REVIEW:

Invasive Meningococcal disease is a rare but potentially devastating disease in travelers. In the past 5 years, significant progress in vaccine development has been made. The purpose of this review is to provide up-to-date information on the current status of risk of meningococcal disease in travelers and vaccine recommendations.

RECENT FINDINGS:

More evidence on cases of meningococcal disease in travelers is now available. The main areas of highest risk for travelers continue to be the Hajj pilgrimage and travel to the meningitis belt. Two new tetravalent conjugate vaccines against serogroups A, C, W135 and Y have been licensed in North America, Europe and other countries. Significant progress has been made in the development of serogroup B vaccines.

SUMMARY:

The vaccine of choice for travelers at risk of invasive meningococcal disease is a tetravalent conjugate meningococcal vaccine. Data on the need for re-vaccination schedules are still lacking, and so are data on immunogenicity in very young children and the elderly. The first vaccine against serogroup B may become available in early 2013 thus expanding the options of broadening the protection against more serogroups for travelers. Furthermore, the development of pentavalent vaccines will increase the uptake of meningococcal vaccines in the future.

Related Articles
Review Meningococcal disease in international travel: vaccine strategies.
J Travel Med. 2005
Review Meningococcal disease in international travel: vaccine strategies.
Wilder-Smith A. J Travel Med. 2005 Apr; 12 Suppl 1:S22-9.
Meningococcal disease: risk for international travellers and vaccine strategies.
Travel Med Infect Dis. 2008
Meningococcal disease: risk for international travellers and vaccine strategies.
Wilder-Smith A. Travel Med Infect Dis. 2008 Jul; 6(4):182-6. Epub 2007 Dec 3.
Review Invasive meningococcal disease and travel.
J Infect Public Health. 2010
Review Invasive meningococcal disease and travel.
Memish ZA, Goubeaud A, Bröker M, Malerczyk C, Shibl AM. J Infect Public Health. 2010 Dec; 3(4):143-51. Epub 2010 Nov 11.
Meningococcal disease and travel.
Clin Infect Dis. 2002
Meningococcal disease and travel.
Memish ZA. Clin Infect Dis. 2002 Jan 1; 34(1):84-90. Epub 2001 Nov 20.
Review Meningococcal vaccine in travelers.
Curr Opin Infect Dis. 2007
Review Meningococcal vaccine in travelers.
Wilder-Smith A. Curr Opin Infect Dis. 2007 Oct; 20(5):454-60.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.